AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-90
Results: 26-50/90
Insulin-like growth factor I - Implications in aging
Authors: Arvat, E Broglio, F Ghigo, E
Citation: E. Arvat et al., Insulin-like growth factor I - Implications in aging, DRUG AGING, 16(1), 2000, pp. 29-40
GH secretagogues in aging
Authors: Arvat, E Giordano, R Broglio, F Gianotti, L Di Vito, L Bisi, G Graziani, A Papotti, M Muccioli, G Deghenghi, R Ghigo, E
Citation: E. Arvat et al., GH secretagogues in aging, J ANTI-AG M, 3(2), 2000, pp. 149-158
Ghrelin-induced growth hormone secretion in humans
Authors: Peino, R Baldelli, R Rodriguez-Garcia, J Rodriguez-Segade, S Kojima, M Kangawa, K Arvat, E Ghigo, E Dieguez, C Casanueva, FF
Citation: R. Peino et al., Ghrelin-induced growth hormone secretion in humans, EUR J ENDOC, 143(6), 2000, pp. R11-R14
Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats
Authors: Seoane, LM Tovar, S Baldelli, R Arvat, E Ghigo, E Casanueva, FF Dieguez, C
Citation: Lm. Seoane et al., Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats, EUR J ENDOC, 143(5), 2000, pp. R7-R9
Interaction between glucagon and Hexarelin, a peptidyl GH secretagogue, onsomatotroph and corticotroph secretion in humans
Authors: Arvat, E Maccagno, B Ramunni, J Giordano, R Broglio, F Gianotti, L Maccario, M Camanni, F Ghigo, E
Citation: E. Arvat et al., Interaction between glucagon and Hexarelin, a peptidyl GH secretagogue, onsomatotroph and corticotroph secretion in humans, EUR J ENDOC, 143(5), 2000, pp. 601-606
Endocrine activities of alexamorelin (Ala-His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2), a synthetic GH secretagogue, in humans
Authors: Broglio, F Benso, A Gottero, C Muccioli, G Deghenghi, R Ghigo, E Arvat, E
Citation: F. Broglio et al., Endocrine activities of alexamorelin (Ala-His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2), a synthetic GH secretagogue, in humans, EUR J ENDOC, 143(3), 2000, pp. 419-425
Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans
Authors: Arvat, E Maccagno, B Ramunni, J Maccario, M Giordano, R Broglio, F Camanni, F Ghigo, E
Citation: E. Arvat et al., Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans, EUR J ENDOC, 143(1), 2000, pp. 99-104
Comparisons among old and new provocative tests of GH secretion in 178 normal adults
Authors: Aimaretti, G Baffoni, C DiVito, L Bellone, S Grottoli, S Maccario, M Arvat, E Camanni, F Ghigo, E
Citation: G. Aimaretti et al., Comparisons among old and new provocative tests of GH secretion in 178 normal adults, EUR J ENDOC, 142(4), 2000, pp. 347-352
Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine
Authors: Broglio, F Benso, A Gottero, C Di Vito, L Aimaretti, G Fubini, A Arvat, E Bobbio, M Ghigo, E
Citation: F. Broglio et al., Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine, EUR J ENDOC, 142(2), 2000, pp. 157-163
Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans
Authors: Arvat, E Di Vito, L Broglio, F Papotti, M Muccioli, G Dieguez, C Casanueva, FF Deghenghi, R Camanni, F Ghigo, E
Citation: E. Arvat et al., Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans, J ENDOC INV, 23(8), 2000, pp. 493-495
Normal IGF-I and enhanced IGFBP-3 response to very low rhGH dose in patients with dilated cardiomyopathy
Authors: Broglio, F Benso, A Arvat, E Aimaretti, G Gottero, C Granata, R Boghen, MF Bobbio, M Camanni, F Ghigo, E
Citation: F. Broglio et al., Normal IGF-I and enhanced IGFBP-3 response to very low rhGH dose in patients with dilated cardiomyopathy, J ENDOC INV, 23(8), 2000, pp. 520-525
The negative GH auto-feedback in childhood: Effects of rhGH and/or GHRH onthe somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue,in children
Authors: Bellone, J Bellone, S Aimaretti, G Valetto, MR Baffoni, C Corneli, G Origlia, C Arvat, E Ghigo, E
Citation: J. Bellone et al., The negative GH auto-feedback in childhood: Effects of rhGH and/or GHRH onthe somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue,in children, J ENDOC INV, 23(3), 2000, pp. 158-162
Sequential administration of arginine and arginine plus GHRH to test somatotroph function in short children
Authors: Bellone, J Aimaretti, G Bellone, S Baffoni, C Corneli, G Origlia, C Cappa, M Ghigo, E
Citation: J. Bellone et al., Sequential administration of arginine and arginine plus GHRH to test somatotroph function in short children, J ENDOC INV, 23(2), 2000, pp. 97-101
Neonatal and adult human heart tissues from normal subjects and patients with ischemic, dilated or hypertrophic cardiomyopathy express insulin-like growth factor binding protein-3 (IGFBP-3)
Authors: Granata, R Broglio, F Migliorino, D Cutrupi, S Baldanzi, G Sireno, M Fubini, A Graziani, A Ghigo, E Pucci, A
Citation: R. Granata et al., Neonatal and adult human heart tissues from normal subjects and patients with ischemic, dilated or hypertrophic cardiomyopathy express insulin-like growth factor binding protein-3 (IGFBP-3), J ENDOC INV, 23(11), 2000, pp. 724-726
DHEA-S levels in hypopituitaric patients with severe GH deficiency are strongly reduced across lifespan. Comparison with IGF-I levels before and during rhGH replacement
Authors: Aimaretti, G Baffoni, C Ambrosio, MR Maccario, M Corneli, G Bellone, S Gasperi, M Degli Uberti, E Ghigo, E
Citation: G. Aimaretti et al., DHEA-S levels in hypopituitaric patients with severe GH deficiency are strongly reduced across lifespan. Comparison with IGF-I levels before and during rhGH replacement, J ENDOC INV, 23(1), 2000, pp. 5-11
Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span
Authors: Ghigo, E Arvat, E Gianotti, L Lanfranco, F Broglio, F Aimaretti, G Maccario, M Camanni, F
Citation: E. Ghigo et al., Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span, J PED END M, 13, 2000, pp. 1493-1502
Effects of subcutaneous sumatriptan on plasma growth hormone concentrations in migraine patients
Authors: Pinessi, L Rainero, I Savi, L Valfre, W Limone, P Calvelli, P Del Rizzo, P Gianotti, L Taliano, M Ghigo, E Arvat, E
Citation: L. Pinessi et al., Effects of subcutaneous sumatriptan on plasma growth hormone concentrations in migraine patients, CEPHALALGIA, 20(4), 2000, pp. 223-227
The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors
Authors: Maccario, M Grottoli, S Procopio, M Oleandri, SE Rossetto, R Gauna, C Arvat, E Ghigo, E
Citation: M. Maccario et al., The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors, INT J OBES, 24, 2000, pp. S96-S99
Alprazolam. a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients
Authors: Grottoli, S Arvat, E Gauna, C Maccagno, B Ramunni, J Giordano, R Maccario, M Deghenghi, R Ghigo, E
Citation: S. Grottoli et al., Alprazolam. a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients, INT J OBES, 24, 2000, pp. S136-S137
Adrenal responsiveness to high, low and very low ACTH 1-24 doses in obesity
Authors: Maccario, M Grottoli, S DiVito, L Rossetto, R Tassone, F Ganzaroli, C Oleandri, SE Arvat, E Ghigo, E
Citation: M. Maccario et al., Adrenal responsiveness to high, low and very low ACTH 1-24 doses in obesity, CLIN ENDOCR, 53(4), 2000, pp. 437-444
Low dose (1 mu g) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease
Authors: Laureti, S Arvat, E Candeloro, P Di Vito, L Ghigo, E Santeusanio, F Falorni, A
Citation: S. Laureti et al., Low dose (1 mu g) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease, CLIN ENDOCR, 53(1), 2000, pp. 107-115
Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa
Authors: Gianotti, L Fassino, S Daga, GA Lanfranco, F De Bacco, C Ramunni, J Arvat, E Maccario, M Ghigo, E
Citation: L. Gianotti et al., Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa, CLIN ENDOCR, 52(6), 2000, pp. 713-720
Reduction of the pituitary GH releasable pool in short children with GH neurosecretory dysfunction
Authors: Aimaretti, G Bellone, S Bellone, J Chiabotto, P Baffoni, C Corneli, G Origlia, C de Sanctis, C Camanni, F Ghigo, E
Citation: G. Aimaretti et al., Reduction of the pituitary GH releasable pool in short children with GH neurosecretory dysfunction, CLIN ENDOCR, 52(3), 2000, pp. 287-293
Short-term fasting abolishes the sex-related difference in GH and leptin secretion in humans
Authors: Maccario, M Aimaretti, G Corneli, G Gauna, C Grottoli, S Bidlingmaier, M Strasburger, CJ Dieguez, C Casanueva, FF Ghigo, E
Citation: M. Maccario et al., Short-term fasting abolishes the sex-related difference in GH and leptin secretion in humans, AM J P-ENDO, 279(2), 2000, pp. E411-E416
Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue
Authors: Cassoni, P Papotti, M Catapano, F Ghe, C Deghenghi, R Ghigo, E Muccioli, G
Citation: P. Cassoni et al., Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue, J ENDOCR, 165(1), 2000, pp. 139-146
Risultati: 1-25 | 26-50 | 51-75 | 76-90